The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 29, 2015

Filed:

Oct. 04, 2013
Applicants:

Somasekhar Bhamidipati, Foster City, CA (US);

Marina Gelman, San Francisco, CA (US);

Pingyu Ding, Foster City, CA (US);

Rajinder Singh, Belmont, CA (US);

Jeffrey Clough, Redwood City, CA (US);

Todd Kinsella, Redwood City, CA (US);

Donald Payan, Hillsborough, CA (US);

Inventors:

Somasekhar Bhamidipati, Foster City, CA (US);

Marina Gelman, San Francisco, CA (US);

Pingyu Ding, Foster City, CA (US);

Rajinder Singh, Belmont, CA (US);

Jeffrey Clough, Redwood City, CA (US);

Todd Kinsella, Redwood City, CA (US);

Donald Payan, Hillsborough, CA (US);

Assignee:

Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/04 (2006.01); C07D 405/04 (2006.01); C07D 487/04 (2006.01); C07D 401/04 (2006.01); C07F 9/6503 (2006.01); C07D 417/04 (2006.01); C07D 471/04 (2006.01); C07D 405/14 (2006.01); C07D 401/14 (2006.01); C07D 213/26 (2006.01); C07D 498/04 (2006.01); C07D 413/04 (2006.01); C07D 417/14 (2006.01); C07D 453/02 (2006.01);
U.S. Cl.
CPC ...
C07F 9/65038 (2013.01); C07D 213/26 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 413/04 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 453/02 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01); C07D 513/04 (2013.01);
Abstract

Described are GCF-8 inhibitors of the formula (I), and pharmaceutically acceptable salts thereof, wherein n, R, R, R, R, X and Z are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for inhibiting GDF-8 in a cell and methods for treating a patient suffering from a disease or disorder, wherein the patient would therapeutically benefit from an increase in mass or strength of muscle tissue.


Find Patent Forward Citations

Loading…